Cours OKYO Pharma Limited London S.E.
Actions
OKYO
GG00BMFG5F62
Produits pharmaceutiques
CA 2024 * | - | CA 2025 * | - | Capitalisation | 51,35 M 46,38 M |
---|---|---|---|---|---|
Résultat net 2024 * | -11 M -9,94 M | Résultat net 2025 * | -15 M -13,55 M | VE / CA 2024 * | - |
Trésorerie nette 2024 * | - 0 | Trésorerie nette 2025 * | - 0 | VE / CA 2025 * | - |
PER 2024 * |
-3,86
x | PER 2025 * |
-4,07
x | Employés | 8 |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 42,63% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Gary Jacob
CEO | Chief Executive Officer | 77 | 07/01/21 |
Keeren Shah
DFI | Director of Finance/CFO | 47 | 01/08/20 |
William Clementi
COO | Chief Operating Officer | - | 01/09/23 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
John Brancaccio
BRD | Director/Board Member | 76 | 10/06/20 |
Willy Simon
BRD | Director/Board Member | 72 | 01/06/15 |
Gabriele Cerrone
CHM | Chairman | 52 | 07/01/21 |
Varia. 1 janv. | Capi. | |
---|---|---|
-3,79% | 87,06 Md | |
+2,76% | 40,25 Md | |
-17,49% | 31,09 Md | |
+54,06% | 24,74 Md | |
-13,13% | 15,91 Md | |
-9,12% | 11,96 Md | |
-15,45% | 11,92 Md | |
-42,56% | 11,61 Md | |
+5,17% | 8,73 Md |